Trial OKed for Rare Disease Gene Therapy
A start-up biotech company says it received clearance from the Food and Drug Administration to begin a clinical trial of […]
XeRo
Posts by XeRo
Forge Biologics Cleared for Clinical Trial of FBX-101, a Krabbe Disease Treatment
The FDA has recently cleared an Investigational New Drug (IND) application for FBX-101, allowing it to move into a […]
Read More… from Forge Biologics Cleared for Clinical Trial of FBX-101, a Krabbe Disease Treatment
FDA Clearance of Investigational New Drug for Patients with Krabbe Disease
We’re pleased to share that the United Leukodystrophy Foundation has shared our press release, marking yet another avenue of informing […]
Read More… from FDA Clearance of Investigational New Drug for Patients with Krabbe Disease
PRESS: BioSpace
Ohio-based startup Forge Biologics closed a $40 million Series A financing roundthat will be used to expand manufacturing capabilities and support […]
Forge Biologics Launches with $40 Million to Manufacture and Develop Gene Therapies
Ohio-based startup Forge Biologics closed a $40 million Series A financing roundthat will be used to expand manufacturing capabilities and support […]
Read More… from Forge Biologics Launches with $40 Million to Manufacture and Develop Gene Therapies
Forge Biologics Launches with $40 Million to Manufacture and Develop Gene Therapies
Forge Biologics, a viral vector gene therapy manufacturing and development company with a platform to develop proprietary gene therapy products, […]
Read More… from Forge Biologics Launches with $40 Million to Manufacture and Develop Gene Therapies
PRESS: Global Genes
Forge Biologics, a viral vector gene therapy manufacturing and development company with a platform to develop proprietary gene therapy products, […]
Gene therapy company raises $40M to launch in Central Ohio
A gene therapy startup in Grove City has raised $40 million in venture capital to both bring biotech to market […]
Read More… from Gene therapy company raises $40M to launch in Central Ohio
PRESS: The Business Journals
A gene therapy startup in Grove City has raised $40 million in venture capital to both bring biotech to market […]